Ki Health Partners, LLC

Stamford, Connecticut 06905

1 studies enrolling now · 3 studies all time

What they study most

Agitation, Alzheimer Disease, Alzheimer's Type Dementia

Studies at this site

• Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type — Recruiting now
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early